IFN-γ–driven MHC class II on gut epithelium induces cytolytic T H 1 cell differentiation and stem cell loss in graft-versus-host disease
Science Immunology · 13.11.2026 · 11 (125)
DOI: 10.1126/sciimmunol.ady3001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 13.11.2026. Verfasst von Motoko Koyama und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Hauptthemen laut MEDLINE: Interferon-gamma, Th1 Cells, Histocompatibility Antigens Class II, Intestinal Mucosa. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
The molecular cues by which CD4 T cells are invoked to mediate lethal gut graft-versus-host disease (GVHD) at the epithelial interface after allogeneic hematopoietic stem cell transplantation are unclear. Here, we demonstrate that MHC class II (MHCII) but not MHC class I expression by intestinal epithelial cells (IECs) within the first 3 days of transplantation promotes lethal GVHD in mice. This was dependent on direct IFN-γ–dependent induction of MHCII on IECs, which expanded perforin/granzyme B–expressing cytolytic donor T H 1 cell while restraining T H 17 cell differentiation locally within the ileum. In contrast, intestinal stem cells (ISCs) were preferentially and progressively depleted by cytolytic T H 1 cells as a result of IFN-γ–induced MHCII expression. Together, IEC-intrinsic IFN-γ signaling is critical for the MHCII-dependent early local generation of cytolytic T H 1 cells that thereafter mediate MHCII-dependent ISC deletion. These data demonstrate a critical IFN-γ–MHCII feed-forward axis in the initiation of cytolytic T H 1 cell–dependent gut disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
- Division of Medical Oncology, University of Washington, Seattle, WA, USA.
- Centre for Experimental Immunology, Lions Eye Institute, Nedlands, WA, Australia.
- Infection and Immunity Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
- Envoi Specialist Pathologists, Brisbane, QLD, Australia.
ORCID-Profile: Motoko Koyama, Albert C Yeh, Françoise Haeseleer, Shruti S Bhise, Iona S Schuster, Ethan L Nelson, Shuichiro Takahashi, Ping Zhang, Simone A Minnie, Daniel S Hippe, Mariapia A Degli-Esposti, Andrew D Clouston, Scott N Furlan, Geoffrey R Hill
Förderung
- National Institutes of Health
Zitieren
APA
Koyama, M., Yeh, A. C., Haeseleer, F., Ensbey, K. S., Bhise, S. S., Schuster, I. S., Legg, S. R. W., Nelson, E. L., Sekiguchi, T., Nemychenkov, N. S., Takahashi, S., Zhang, P., Minnie, S. A., Hippe, D. S., Degli-Esposti, M. A., Clouston, A. D., Furlan, S. N., & Hill, G. R. (2026). IFN-γ–driven MHC class II on gut epithelium induces cytolytic T H 1 cell differentiation and stem cell loss in graft-versus-host disease. Science Immunology, 11(125). https://doi.org/10.1126/sciimmunol.ady3001
Vancouver
Koyama M, Yeh AC, Haeseleer F, Ensbey KS, Bhise SS, Schuster IS, et al. IFN-γ–driven MHC class II on gut epithelium induces cytolytic T H 1 cell differentiation and stem cell loss in graft-versus-host disease. Science Immunology. 2026;11(125). doi:10.1126/sciimmunol.ady3001
BibTeX
@article{Koyama2026,
author = {Koyama, Motoko and Yeh, Albert C and Haeseleer, Françoise and Ensbey, Kathleen S and Bhise, Shruti S and Schuster, Iona S and Legg, Samuel R W and Nelson, Ethan L and Sekiguchi, Tomoko and Nemychenkov, Nicole S and Takahashi, Shuichiro and Zhang, Ping and Minnie, Simone A and Hippe, Daniel S and Degli-Esposti, Mariapia A and Clouston, Andrew D and Furlan, Scott N and Hill, Geoffrey R},
title = {IFN-γ–driven MHC class II on gut epithelium induces cytolytic T H 1 cell differentiation and stem cell loss in graft-versus-host disease},
journal = {Science Immunology},
year = {2026},
volume = {11},
number = {125},
doi = {10.1126/sciimmunol.ady3001}
}
EUVIMED